Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone to reduce preterm birth in women at risk
IRCT201108286808N2Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone in preterm birth, sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Rate of preterm birth. Started Sep 2008; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT201108286808N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108286808N2.